Home
Patents

Work Area: Patents

The sword, the shield, the olive branch – NuCurrent’s path to IP value creation

In an exclusive interview, the company’s CEO Jacob Babcock details its journey to becoming a technology licensing business

A new wave of US biosimilar patent disputes begins

After a lull in biologic versus imitator disputes, Regeneron has sued Mylan and more litigation is likely to follow

The patent challenges of the Indian company set to become the world’s biggest biosimilars business

In an exclusive interview Biocon Biologics’ chief IP counsel explains the issues that he and his team focus on – and how an upcoming, big-ticket merger will lead to change

Latest content

IPValue – the licensing business that rarely goes to court

Despite holding thousands of patents and being active for over 20 years, Docket Navigator data shows that the firm’s entities have filed just 32 litigation actions since 2008

15 August 2022

ITC setback for Sonos in its high stakes patent battle with Google

The search giant has also hit the smart-speaker innovator with a new round of US district court litigation

12 August 2022

How Brazil is becoming a more favourable jurisdiction for life sciences patentees

Contrary to appearances, Latin America’s largest economy is developing a more favourable environment for pharma and biotech innovators.

12 August 2022

No decision on possible WiLAN sale yet taken, says Quarterhill CEO

A strategic review that began in December 2021 is ongoing with several options being explored and meanwhile the firm continues to do deals

11 August 2022

What made Colombia an attractive venue for Ericsson in its patent battle with Apple

The Swedish company has been a prolific filer in a country whose judicial processes strongly favour plaintiffs

11 August 2022

UK decision highlights risk surrounding patent enforcement strategies focused on Amazon

The High Court ruling is the country’s first on whether the use of the online platform’s IP procedures can constitute an actionable unjustified threat

11 August 2022

IPBC Asia all set for Tokyo this autumn

The Asia-Pacific region’s premier event about the business of IP will take place in the Japanese capital from 31 October to 2 November

10 August 2022

Bolar-like hurdle for generics

The judgment of the Ankara IP court in a case involving a marketing authorisation application demonstrates that an exemption similar to the so-called Bolar exemption can apply to Gx pharmaceutical companies.

10 August 2022

Adeia president reveals strategy as spin-out from Xperi approaches

Paul Davis plans to continue driving growth in the firm’s media and semiconductor IP portfolios

09 August 2022

Seven steps to secure and safeguard US patents for AI-assisted inventions

The Federal Circuit’s recent Thaler v Vidal ruling may create opportunities for accused infringers to challenge the validity of rights that claim inventions obtained, even in part, through such systems

09 August 2022

Get unlimited access to all IAM content